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I The separate effects of exposure for six hours to cold (8"C), hypoxie (4267 m,) and simulated altitude 
(8O0 at  4267 m.)have been studied on ten human subjects in e deoompreesion qhamber, with respect to 
the changes in blood cortisol, ADH and urinary catecholamines. Changes in blood cortisol, PBI, ADH 
urinary excreticn of 17-keto steroids and urine volume have been recorded on another ten subjects on 
acute exposure to high altitude (3505 m.). Changes in the same parameters alongwith urinaly testoste- 
rone level, have been recorded on another 20 subjects on prolonged exposure for two years to high alti- 
tude (3505 m.). The r snlts have been discussed. J Hormones have beeti r ported to play a major role in the maintenance of resistance to environmental 
changes1. The adrenal hormones, both medullary and cortical appear to be the most important regu- 
latory factors2. The output of ~drenal cortical hormones increases in response to acute hypoxia but 
returns back to the sea level values within 3-21 days of stay at high altitude3-'. Increased secretion 
of epinephrine and nor-epinephrine have been reported. to indirectly decrease the altitude toleran.ces 
while cortisone and ACTH secretions stimulateg it. Adult female rats have been reported to be much 
@ore resistant to hypoxic stress than the males, perhaps because their adrenals are larger in size2. In 
mic:, resistance to anoxia is reported to be increased by administration of posterior lobe extractslo. ADH 
has been fiported to regulate the water balance under hypoxic stressll. Diuresis has been reported 
to occur on exposure to actual or simulated altitude stress12. Thyroid activity has beenreported to be 
depressed during stay a t  high altitude13 while Surks l4 et. al. reported elevated, FBI leyel under hypoxic 
stress, and Yerzerl6 et. al. correlated the increased adrenocortical h c t i o n  with decreased thyroid acti- 
vity. In rats, thyroidcctomy and administration of propylthiouracil have been reported to increase 
while feeding of desiccated thyroid to decrease resistance to hypobaric hypoxial6. 
Brief exposure of rats to simulated altitude has been reported to cause testicular tension, impairment 
of spermatogenesis and degeneration of the germinal epithelium but these changes regress to normal on 
return to sea level conditions1'. Decrease in sperm concentration, azoospermia, decreased sperm moti- 
lity and increased abnormal forms have been reported ls,l9 in sheep transported to high altitude. Human 
subjects on exposure to 4267 m.  for four weeks have been reported20, to show decrease in sperm count, 
a significant increase in the abnormal forms, deareased motility but an elevation in seminal fructose 
level. Seminal pH was also reported to have been raised but seminal citr'c acid remained normal until 
descent to sea level which led to recovery. It has been reportad that sea level residents transferred to 
high altitude show a significant decrease in the urinary testosterone level on the third day of exposure21. 
A decreased excretion of 17-ketosteroids in human subjects a t  high altitude has also been note$. 
Results of different investigations carried out by us on human subjects under various periods of stay 
a t  high latitude and on exposure to simulated high altitude conditions, hypoxia and told, in a tempe- 
rature controlled human decompression chamber are presented in this paper. 
1 
N A T E R I A L S  A N D  M E T H O D S  
Phase I : Studies i n  the l'ernperature Cofitrolled Hman Decompressior, Ckmber 
Two groups of fivd adult male human subjects of the age group 20-30 years were exposed for six hours 
in the decompression chamber, a t  intervals of one week between exposures, under the following stresses :- 
(i) Cold stress only a t  S°C witholit hypoxia. 
(ii) Hypoxic stress only simulating an altitude of 4267 m. at  28°C (room temperature). 
(iii) Altitude stress simulating 4267 m. at  8OC (Cold and hypoxia). 
Their urinary catecholamines, plasma cortisol and blood ADH levels were determined before and 
immediately after six hr, exposure to the stress concerned, 
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Phase II  : Studies Under Actual Altitude Stress (3505 m.) 
(a) Slwrt term acute eqosure,  to high altitude A;. temp. (1O0C): A gmup of 10 adult male human sub- 
jects bf the age group 20-30 years, who are ncrmal residents of sea level regions, were examined a t  the 
base laboratory for their se? level (S.L.) values of blood cortisol, serum PBI, blood ADH, 24 hr. ex- 
cretilons of 17-Ketosteroids and 24 h'r. urine vdume. These subjects were then airlifted to an altitude 
of 3605 m. and exami~ed periodically for the same .para~.eters during their stay for 18 days at high 
altitude. They were again examined, after three days of their descent, by air, to  S.L. (R.S.L.) 
(b)  B f f a t  of prablzged stay at high altitude :- Twenty subjects similar in nature to those studied 
under (a) were initially examined a t  the base laboratory and'their sea level (S.L.) values for serum PBI, 
plasma cortisol, blood ADH, 24 hr. minary testosterone and 17-ketosteroids excreti?n were determined. 
These subjecls went up to an altitude of 3505 m. .by road and stayed there for a period of two years in- 
cluding one to two months stay each year a t  their sea level residence and re-ente to high altitude 
by road. The above parameters in these subjects were agaip determined within 15days of their return 
to the base laboratory a t  sea level and these values (R.S.L.) compared wiih the initial (S.L.) values. 
Serum PBI was determined by the methcd of Barker and Hurnphery22, plasma cortisol by the 
fluorimetric methcd of van de vies23, ADH by-the bioassaymethod of Y0shid8~ et. al., catecholamines 
by the fluorimetric method of Sobel and Henrys urinary 17-Ketosteroids by the method of Drekter26 
and urinary testosterone by the method of Szereday and Saclns27. 
0 
- R E S U L T B  
-. . 
Hormonal changes observed in human subjeots exposed to various stresses in the %mperahre 
controlled human decompression chamber are given in Table 1. 
TARLE 1 
(Meanf SE for 4 su7)jeots) i 
i 
B a a l  . W Hypoxia Altitude 
Parameter \ 28% at ?+ -goC at  ZBQC at 8°C at  




Urinary 36.3f 58.2 & 47.3 f 48.3 f 
exoretion of catecholamines p 916 hrs 7.30 7. 31 8.06 10. 42 
* ** ** 
Plasma 8.63f 9.54& 12.64% 17' 92f 
cortisol p g/100 ml. 2.39 0.20 0.32 0.00 - 
- 
* 
' 2 . 2 4  2.23f 4.67f 
0 . 3 r  
2.88-1- 
Blood ADH p zclml. - 0.37 ' 0.75 0.70- 
1 
3 
Signifimnce of difference from basalvalue. 
*P<OS06 **P<O.OQl 
i 
. Urinary excreticn of oatecholamines was significantly raised on exposure to cold, plasma cortisol was 
raised both in hypoxia and altitude stress while blood ADR was high on hypoxic atress only. .? i 
a 
, mgressive changes in the levels of blood cortisol PBJ, ADH and' urine volume of lowlanders 
during their short stay a t  actyal high altitude (3505 m.) are given in Table 2. Plasma cortisol began to 
rise within three days of arrival a t  high altitude, reaching the maximum level in 7- 9 days. After 13 
days it appeared to stabilise for the rest of the period of stay (18 days) at  high altitude. On return 
to the sea level it again showed a &harp rise. All these changes are statistically si@ficant, 
Plasma Cortisol 18.0& 22.50f 49.Of 55.501 40.50& 21.501 21a50& 3 2 - 0 1  
pg/100 ml. . 0. &5 1.82 3- 383 3'75 2? 856 1.125 1.25 2.98 
\ *** *** *** *** *** 
PBI (serum) , 6 9 5.0& 5.2% 5'3f 5*is;5& 5.55f . 7.0+ 
pg/lOO ml. 0.19 0.191 0.190 $;215 0.203 0- 195 .. 0.501 ** 
ADH (Blood) 1 .951  1-40f 2.23kY 3.40 f . . 2.50% .. 1.50% 
pIm1. 0.112 0.107 0.207 0.05 . . 0.15 . . 0.075 ** *** , *** 
Urinary excretion 8 . 0 0 1  . . 17' OO& . . 24. OOf 23-84 .. 9.5% 
of 17-ketosteroids, mgin 24 hrs. 1.00 . . 1. 6 . . 2.1 1.9 .. 1.2 
* 
Urine Volume, 1030f 1040f 12001 1339f 1238& 1217.f .. 1016k 
m 1/24 bra, 60 50 55 110 70 70 . . 65 
- - --- 
---- - ---- 
Significanoe of difference from B.L. </ 
*P<O0 05; **P<10,. 01; ***P<Os 001 
he first three days of arrival-at high altitude and maintained a .signifi- 
&'&y at  h+& altitude. On mtum to sea level FBI rise to the original 
1 
ADH level showed a decrease within the first t! rJe days followedbby a rise in 4-6 days, reaching a( 
maximum at 7-9 days which is statistically significant. At 13-15 days the level W ~ S  lower than the. 
maximum and on return to &a level it decreased further below the original S.L. value. I 
Twenty-four hours u r i n a j  excretion of 17-Ketosteroids progressively rose in the subjects at -dig'& 
altitude till 10-12 days and dr$pd back to S.L. value on return to S.L. Urine volume for 24 hr. 
gradually rose a t  high altitude till 7-9 days and then gradually decreased but mainkained a higher level 
till 13-15 days. I t  droppd. to the original S.L. value on return to S,L. 
Hormonal changes in subjects aftek a pzobged st39 sf two years at high altitude aro given in 
Table 3. Serum PBI level and 24 hr-uriuqexoretion of testosterone were &till significantly lower than 
the original S.L. value6 
TABLE 3 
HORMONAL OHANCIS ON PROLONUED STAY AT PIUB ALTITUDE (3505 m). 
Sea Level After two years' Significance of 
Parameter studied (8.L.) stay a t  S g h  change 
'altitude (R.S.L.) 
_dd_3_d_d_3_3_d_C __---- ---..-..-- - - + - -  --- .. . ------+-.--_- 
Berum FBI 6.9f 5.59& P<O. 05 
0.19 0.6008 pg/lOO ml. 
Plasma C h t i s ~ l  18.0f 18 '43f NS 
pg/100 ml. 0'485 2.9923 
Blood ADH 2. 6 1  '2.66f NS 
0- 6455 
~ 1 ~ 1 1 .  0. 218 
Urinary testosterone 30- 0 & 18.26& p;W1 
pg/24 hrs. 2. 19 1.8098 
Urinary 17-ketosteroids, 10- OO& 12.38& Nb 
mg/24 hrs. 0.09 1.30 
- 
D I S C U S S I O N  
The i~volvement of the adrenal cortex in the-mammalian response to hypoxic stress was first suggested 
by Rabenno23 although he concluded that the increased cortical activity of the gland in animals exposed 
to high altitude was due more to the cooler ambient temperatures than to thed.ecreased oxygen tension 
encountered in mountainous regions, Giragossintz and Sund~troern~~ suggested that there was a 
greater need by the body for adrenal cortical hornones\ under conditions of hypoxia. Interest 
in this problem during the second world war3O stimulated research which established that hypoxia 
is a powerful stimulator of the adrenal cortex3l-s6. 
Our studies Table 1 suggest that the adrenal medulla is more stimulated than the cortex under 
the cold stress whereas the reverse is true, as suggested by earlier observers, for the hypoxic stress. 
At high altitudes, where both these stresses are involved, a mixed effect is observed, although tbe effect 
cn cortisol activity is more apparent. Any sudden change of altitude has been found to bring about a 
rise in blood cortisol level as has been clearly observed in our subjects who showed a rise in blood 
cortiml level on being airlifted to 3505 m. from the sea level and again on being flown back to sea 
level after stabilization of the cortisol level a t  high altitude after 18 days stay, (Table 2). On 
prolonged stay a t  high altitude, however, adrenal cortical activity seem to return to the sea level 
value as is evidenced by the plasma cortisol levels a t  S.L. and after two years of stay at high altitude 
(Table 3). 
The antidiuretic hormone (ADH) secretion had been postulated to be lower a t  high altitude lead- 
ing to diuresis? as normal human subjects have been reported to suffer frcm diuresis on arrival a t  
high altitude3'. Our observaticns in the decompression chamber show that (Table 1) hypoxia has a direcb 
effect in increasing ADH secretion whereas cold or altitude and cold exposure doesn't alter the blood 
ADH level sigaificantly. 
Our studies on 1owlan.ders taken to high altitude (Table 2) have shown that the ADH level falls 
slightly on arrival a t  high altitude and shows a gradual rise after three days, reaching a maximum level 
in 7-9 days, while the urine output also shows a sigificant rise at the same time as the maximum levels 
of both ADH and cortisol in the blood, i.e., at  7-9 days of stay at high altitude. It is apparent, 
therefore, that the high ADH level a t  nine hays is not able to exert its usual antidiuretic effect, 
may be due to a simultaneous rise in the plasma cortisol level, a normal adaptive phenomenon. 
According to Currie and Ullrnanns8, when the pituitary ~drenal system is activated by stress, 
both vasopressin and adrenal steroids are released. In such conditions, whether a person will exhi- 
bit antidiuresis or polyurea, apparently depends upon the equilibx4urn between vasopressin and the 
adrenal steroids. For example, patients undergoing severe stress with demonstrably increased adre- 
nocortical activity excrete large volumes of relatively dilute urine even when dehydrated. Thisoccurs 
despite marked increase of ADH in plasma and urine and there is only a slight antidiuretic respcnse to 
administered ADH: suggesting that the renal action of ADH is antagonised by the adrenal steroids39. 
In our studies, therefore, the raised ADH level could not exert the usual antidiuretic effect sinw the 
cortisol level had risen simultaneously to antagonise the renal action of ADH. This explains how normal 
subjects have been observed to eXhibit diuresk a t  high altitude despite raised ADH levels. 
It would be interesting to mention here, that persons susceptible ta  pu?monary 0edem.a fail to 
show the ncrmal adaptive phenomenon of rise in blood cortisol on arrival a t  high altitude, or tb.e.y fail 
to maintain a raised cortisol level for suRcient period to counteract the renal effect of the raised ADH 
lcvel40. Oliguria, as ncted by ~Inder Singhl%t. al., in such cases may, therefore, be due to thisuncom- 
pensated ADH rise related to failure of the normal cortical response. Attempts to raise the blood 
cortisol level in such cases should appear helpful in controlling the. onset of pulmonary oedema. More- 
over, cortocosteroids probably protect against hypoxia by facilitating aerobic metabolism41. 
Thyroid function a t  high altitude has been reported- to be depressed by many w o r k e r ~ ~ ~ - ~ 4  while 
increased activity has also been 46. Our observatioc,~ on lowlanders taken to high aiti- 
tu& (Tabh 2) support decreased activity as evidenced by a low PBI kvel within the first three days 
of arrival with a slight tendency to rise till 10-12 days when i t  gets stabilized at a lower level. The 
lower level continues during the stay a t  altitude even after two years (Table 3). On return to sea 
level, however, PBI promptly returns to the initial level (Table 2). Experimental rats 
, 
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subjected to high altitude hypoxia exhibit no visible pathologich changes but there is nevertheless marked 
hypofunctioning of the gland4'> 48. The thyroid hypofunction a t  high altitude has been suggested to lead 
to a series of complex changes like retardation of growth, fall in fertility and in severe cases even total 
sterility 4*53. 
Timiras5 et. aZ. reported that human subjicts showed ir,creased exereti, n of 17-Ketosteroids for the - 
f is t  three days of stayrat 3800 m., urinary and plasma level of all adrenocortical hormcnes and their 
metabolites appeared to be related to the duratitn of exposure and the degree of acclimatisation. They 
rose for the first three days of each sojourn at altitude and then reduaed to the sea level values. S i ~ i ~ ~  
did not find increased excretion of 17-ketosteroids and a few of his subjects on the Himalayan expe- 
Uition showed decreased excretion of 17-ketostercids a t  6096 m. E l i ~ a b e t h ~ ~  also noted a decreased 
excretion of 17-Ketosteroids a t  20,000 ft; whi'e there was an increase in the excretion of 17-hydroxy 
corticoids. 1 
The. excretion of 17-ketosteroids in our subjects a t  high altitude doubled in 4-6 days of stays 
(Table 2) and attained, a maximum level in 10-12 days .after which there was no further rise, and as 
evidenced by our observation on subjects after two years stay at high altitude (Table 3) there must 
have been a gradual decline in excretion bringing the level to just slightly above the sea level value. 
Since the l?-ketosteroids are a complex mixture of  omp pounds which may originate from several 
glandular peroursors, some of whicb are not androgens, its usefulness as an index of androgen function 
is limited and so i t  cannot be ascertained whether this initial rise of 17-ketosteroids is due to increased 
tasticular activity or is the result of increased adrenal cortex activity as noted by us and also by 
previous workers (Loc-cit). Testosterone level of blood or its excretion level only can give useful indi- 
cations of testicular functit n a t  high altitude. It was n.ct possible for us, for technical reasons, to 
estimate gradual changes in testosterone excretion at high altitude. This was done only okce a t  sea 
level before inducticn to high altitude and again at the end of two years stay a t  high altitude. 
The results (Table 3)-.~idicate a significant decline in urinary testosterone after two years stay a t  
high altitude. 
MongeS6 f0un.d that cattle and domestic cat show signs of reproductive failure, a t  altitudes of 3350- 
4500 m, ' The failure of the male fertility was attributed to exfoliation c f the germ cells into the ducts of 
the epididymis before maturation. The spermatczoa were found to be outnumbered by immature 
cells. Azoospermia, decreased sperm motility and deviations of pH have also been observed6' b9. 
Both folliciilar activity and Leydig cell activity thus appear to be suppressed a t  high altitude. 
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